ORIGINAL ARTICLES
Improved outcomes for hospitalized asthmatic children using a clinical pathway

https://doi.org/10.1016/S1081-1206(10)62514-8Get rights and content

Background

Although asthma clinical pathways are used with increasing frequency, few controlled studies have evaluated the clinical and cost effectiveness of these pathways.

Objective

To evaluate the effect of an inpatient asthma clinical pathway on cost and quality of care for children with asthma.

Methods

One hundred forty-nine children were treated for status asthmaticus using an asthma clinical pathway in a children's hospital between September and December 1997. Thirty-four of 149 children treated with the clinical pathway were randomly selected. A retrospective cohort control group of non-pathway patients (N = 34) was matched with each pathway patient by age, race, gender, co-morbidities, asthma severity score, ICU admission, and time of year admitted. Differences between the two groups in length of stay, total costs, readmission rate, inpatient management, and discharge medications were compared.

Results

Length of stay was significantly lower in the clinical pathway group compared with the control group (36 hours versus 71 hours, P < .001) and total costs decreased significantly ($1685 versus $2829, P < .001) as a result of the pathway. Asthmatic children on the clinical pathway were significantly more likely than the control group to complete asthma teaching while hospitalized (65% versus 18%, P < .001), to be discharged with a prescription for a controller medication (88% versus 53%, P < .01), and to have a peak flow meter (57% versus 23%, P < .05) and a spacer device (100% versus 71%, P < .001) for home use.

Conclusion

Implementation of this inpatient clinical pathway led to a decrease in length of stay and a reduction in total cost while improving quality of care for hospitalized asthmatic children.

REFERENCES (30)

  • Center for Disease Control

    Asthma mortality and hospitalization among children and young adults -United States 1980–1993

    MMWR

    (1996)
  • KB Weiss et al.

    An economic evaluation of asthma in the United States

    N Engl J Med

    (1992)
  • National Heart, Lung and Blood Institute
  • EF Crain et al.

    Pediatric asthma care in US emergency departments

    Arch Pediatr Adolesc Med

    (1995)
  • Agency for Health Care Policy and Review

    Practice guidelines: overview of agency for health care policy and research efforts

    (1995)
  • Cited by (98)

    • Defining Treatment Response for Clinical Trials of Pediatric Acute Asthma

      2023, Journal of Allergy and Clinical Immunology: In Practice
    • Direct Medical Cost of Pediatric Asthma in Jordan: A Cost-of-Illness Retrospective Cohort Study

      2022, Value in Health Regional Issues
      Citation Excerpt :

      Even though severe asthma is not common, its contribution to total healthcare resource utilization and related costs is high.44-47 Evidence from intervention evaluation studies suggests that asthma among school-age children can be controlled, and significant cost savings can be achieved.48-55 In the current study and in line with other studies,36,56,57 the total annual direct medical cost per patient increased with asthma severity.

    View all citing articles on Scopus

    Financial support provided by Children's Hospital of The King's Daughters

    View full text